HLA-G and melanoma: NK cells that received HLA-G from melanoma cells lost their proliferation and tumor-killing capacity and suppressed other NK cells cytotoxicity locally and transiently [212], while the occurrence of CD3+HLA-Gacq+T cells was significantly correlated with poor prognosis in multiple myeloma [213].